Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChromX Health has developed the world’s first chip-based miniaturized gas chromatograph for non-invasive breath analysis with parts-per-trillion sensitivity. Their Class II medical device is certified in China and deployed in physical examination centers and community healthcare networks. Over 30 clinical trials are underway with leading hospitals to validate its utility across multiple indications. The company is expanding into home monitoring devices and chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChromX Health.